Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1975 Aug;28(8):659–663. doi: 10.1136/jcp.28.8.659

Muscle fibre type changes in hypothyroid myopathy.

R O McKeran, G Slavin, T M Andrews, P Ward, W G Mair
PMCID: PMC475797  PMID: 1184764

Abstract

Changes in muscle fibre type in hypothyroid myopathy were studied by serial percutaneous needle biopsy of vastus lateralis before and during treatment with L-thyroxine. A type II fibre atrophy and loss was found, which correlated with the clinical and biochemical evidence of a myopathy. The type II fibre atrophy was corrected by L-thyroxine but type II fibre loss was still apparent in severely myopathic patients up to two years after starting treatment. The pathogenesis and significance of type II fibre atrophy and loss are discussed in relation to prognosis.

Full text

PDF
659

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTROM K. E., KUGELBERG E., MULLER R. Hypothyroid myopathy. Arch Neurol. 1961 Nov;5:472–482. doi: 10.1001/archneur.1961.00450170010002. [DOI] [PubMed] [Google Scholar]
  2. Brooke M. H., Engel W. K. The histographic analysis of human muscle biopsies with regard to fiber types. 1. Adult male and female. Neurology. 1969 Mar;19(3):221–233. doi: 10.1212/wnl.19.3.221. [DOI] [PubMed] [Google Scholar]
  3. Brooke M. H., Engel W. K. The histographic analysis of human muscle biopsies with regard to fiber types. 2. Diseases of the upper and lower motor neuron. Neurology. 1969 Apr;19(4):378–393. doi: 10.1212/wnl.19.4.378. [DOI] [PubMed] [Google Scholar]
  4. DUBOWITZ V., PEARSE A. G. Reciprocal relationship of phosphorylase and oxidative enzymes in skeletal muscle. Nature. 1960 Mar 5;185:701–702. doi: 10.1038/185701a0. [DOI] [PubMed] [Google Scholar]
  5. ENGEL W. K. MUSCLE BIOPSY. Clin Orthop Relat Res. 1965 Mar-Apr;39:80–105. [PubMed] [Google Scholar]
  6. Edström L. Selective atrophy of red muscle fibres in the quadriceps in long-standing knee-joint dysfunction. Injuries to the anterior cruciate ligament. J Neurol Sci. 1970 Dec;11(6):551–558. doi: 10.1016/0022-510x(70)90105-x. [DOI] [PubMed] [Google Scholar]
  7. Edström L. Selective changes in the sizes of red and white muscle fibres in upper motor lesions and Parkinsonism. J Neurol Sci. 1970 Dec;11(6):537–550. doi: 10.1016/0022-510x(70)90104-8. [DOI] [PubMed] [Google Scholar]
  8. Edwards R. H. Percutaneous needle-biopsy of skeletal muscle in diagnosis and research. Lancet. 1971 Sep 11;2(7724):593–595. doi: 10.1016/s0140-6736(71)92165-9. [DOI] [PubMed] [Google Scholar]
  9. Fessel W. J. Myopathy of hypothyroidism. Ann Rheum Dis. 1968 Nov;27(6):590–596. doi: 10.1136/ard.27.6.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fessel W. J., Raas M. C. Autoimmunity in the pathogenesis of muscle disease. Neurology. 1968 Nov;18(11):1137–1139. doi: 10.1212/wnl.18.11.1137. [DOI] [PubMed] [Google Scholar]
  11. GRAIG F. A., SMITH J. C. SERUM CREATINE PHOSPHOKINASE ACTIVITY IN ALTERED THYROID STATES. J Clin Endocrinol Metab. 1965 Jun;25:723–731. doi: 10.1210/jcem-25-6-723. [DOI] [PubMed] [Google Scholar]
  12. Griffiths P. D. Serum enzymes in diseases of the thyroid gland. J Clin Pathol. 1965 Sep;18(5):660–663. doi: 10.1136/jcp.18.5.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hayashi M., Freiman D. G. An improved method of fixation for formalin-sensitive enzymes with special reference to myosin adenosine triphosphatase. J Histochem Cytochem. 1966 Aug;14(8):577–581. doi: 10.1177/14.8.577. [DOI] [PubMed] [Google Scholar]
  14. Johnson M. A., Polgar J., Weightman D., Appleton D. Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurol Sci. 1973 Jan;18(1):111–129. doi: 10.1016/0022-510x(73)90023-3. [DOI] [PubMed] [Google Scholar]
  15. LAMBERT E. H., UNDERDAHL L. O., BECKETT S., MEDEROS L. O. A study of the ankle jerk in myxedema. J Clin Endocrinol Metab. 1951 Oct;11(10):1186–1205. doi: 10.1210/jcem-11-10-1186. [DOI] [PubMed] [Google Scholar]
  16. NICKEL S. N., FRAME B., BEBIN J., TOURTELLOTTE W. W., PARKER J. A., HUGHES B. R. Myxedema neuropathy and myopathy. A clinical and pathologic study. Neurology. 1961 Feb;11:125–137. doi: 10.1212/wnl.11.2.125. [DOI] [PubMed] [Google Scholar]
  17. OZKER R. R., SCHUMACHER O. P., NELSON P. A. Electromyographic findings in adults with myxedema: report of 16 cases. Arch Phys Med Rehabil. 1960 Jul;41:299–307. [PubMed] [Google Scholar]
  18. PADYKULA H. A., HERMAN E. The specificity of the histochemical method for adenosine triphosphatase. J Histochem Cytochem. 1955 May;3(3):170–195. doi: 10.1177/3.3.170. [DOI] [PubMed] [Google Scholar]
  19. Pleasure D. E., Walsh G. O., Engel W. K. Atrophy of skeletal muscle in patients with Cushing's syndrome. Arch Neurol. 1970 Feb;22(2):118–125. doi: 10.1001/archneur.1970.00480200024002. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES